[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366332-105":59,"doc-detail-366332-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","trends-in-urinary-tract-cancer-incidence-in-golestan-province-iran-a-16-year-population-based-study","Trends in urinary tract cancer incidence in Golestan province, Iran - a 16-year population-based study","","Urinary tract cancers, especially bladder and kidney cancers, drive substantial global mortality. In Iran, including Golestan province, reported incidence trends appear to be rising, increasing the need for evidence-based planning. This 16-year population-based study evaluates time trends to characterize cancer burden in the region and supports health policy decisions aimed at reducing morbidity and mortality from urinary tract malignancies.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/trends-in-urinary-tract-cancer-incidence-in-golestan-province-iran-a-16-year-population-based-study/366332/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/trends-in-urinary-tract-cancer-incidence-in-golestan-province-iran-a-16-year-population-based-study/366332.png","ImageObject",300,407,{"name":92,"@type":93},"Stanford","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the purpose of the 16-year study in Golestan province?","Question",{"text":112,"@type":113},"The study aimed to analyze cancer trends and provide information to support health policy planning to reduce the burden of urinary tract cancers in Golestan.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data source and time period were used to calculate incidence trends?",{"text":117,"@type":113},"Data came from the Golestan Population-Based Cancer Registry (GPCR), covering urinary tract cancer cases from 2004 to 2019.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study report about incidence rates for kidney and bladder cancer?",{"text":121,"@type":113},"Kidney cancer had an age-standardized rate (ASR) of 2.32 per 100,000, while bladder cancer had an ASR of 5.93 per 100,000.",{"name":123,"@type":110,"acceptedAnswer":124},"Were incidence trends increasing over time, and who had higher rates?",{"text":125,"@type":113},"Estimated annual percentage change indicated an increase in incidence for both kidney and bladder cancers. Men and urban residents experienced higher incidence rates than women and rural residents.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},366332,1790196263,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":46,"preview_page_count":19,"preview_urls":148},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Rahatijafarabad et al. BMC Cancer (2025) 25:1227 BMC Cancer  \n[https://doi.org/10.1186/s12885-025-14641-8](https://doi.org/10.1186/s12885-025-14641-8)  \nRESEARCH Open Access  \nTrends in urinary tract cancer incidence in Golestan province, Iran: a 16-year population-based study  \nBehnaz Rahatijafarabad 1, AmirHoushang Poorkhani2, Fatemeh Esfandiari3, SeyyedMehdi Sedaghat4,  \nFatemeh Ghasemi-Kebria 1, Susan Hasanpour-Heidari 1, Saeid Amirkhanlou5,6* and Gholamreza Roshandel 1,6*  \nAbstract  \nBackground Urinary tract cancers (UTC), particularly bladder and kidney cancers, are associated with high mortality rates globally. In Iran, and specifically in Golestan province, an increasing trend in the incidence of these cancers has been reported. This study aims to analyze cancer trends and inform health policy planning to reduce the burden of these diseases in Golestan.  \nMethods Data was collected from the Golestan Population-Based Cancer Registry (GPCR) covering cases of UTC, particularly kidney and bladder cancer from 2004 to 2019. Crude and age-standardized rates (ASR) of kidney and bladder cancers were calculated and presented per 100,000 person-years. Estimated annual percent changes (EAPC) of the ASRs were calculated to investigate time trends in incidence rates.  \nResults The ASR for kidney cancer was 2.32 per 100,000, with rates of 2.75 for men and 1.91 for women. Bladder cancer had an ASR of 5 . 93, with 9.46 in men and 2.52 in women. Urban populations experienced higher incidence rates as 2.71 for kidney cancer and 7.01 for bladder cancer versus 1.87 and 4.80 in rural areas, respectively. The estimated annual percentage change in incidence was 3 . 68% for kidney and 1. 56% for bladder cancer.  \nConclusion Our findings suggest high rates and increasing trends in incidence of kidney and bladder cancersin Golestan. The study indicates higher kidney and bladder cancer rates in men and urban residents. Further investigations are warranted to assess the effects of risk factors like smoking, opioid drug use and agricultural factors on incidence of urinary tract cancers in this population.  \nKeywords Kidney, Bladder, Cancer, Time Trend, Incidence  \n*Correspondence:  \nSaeid Amirkhanlou[drsam74ir@ymail.com](drsam74ir@ymail.com)[ ](drsam74ir@ymail.com)Gholamreza Roshandel [roshandel_md@yahoo.com](roshandel_md@yahoo.com)  \n1Golestan Research Center of Gastroenterology and Hepatology, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran  \n2Cancer Research Center, Jorjani Clinical Sciences Research Institute, Golestan University of Medical Sciences, Gorgan, Iran 3Department of Surgery, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran  \n4Deputy of Public Health, Golestan University of Medical Sciences, Gorgan, Iran  \n5Department of Internal Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran  \n6Sayyad Shirazi Hospital, Sayyad Shirazi Boulevard, Gorgan, Iran  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nRahatijafarabad et al. BMC Cancer (2025) 25:1227  \nIntroduction  \nUrinary tract cancers, ","cbCaikv3EvWA2JWT","https://ap.wps.com/l/cbCaikv3EvWA2JWT","pdf",1065155,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What was the purpose of the 16-year study in Golestan province?\",\"answer\":\"The study aimed to analyze cancer trends and provide information to support health policy planning to reduce the burden of urinary tract cancers in Golestan.\"},{\"question\":\"Which data source and time period were used to calculate incidence trends?\",\"answer\":\"Data came from the Golestan Population-Based Cancer Registry (GPCR), covering urinary tract cancer cases from 2004 to 2019.\"},{\"question\":\"What did the study report about incidence rates for kidney and bladder cancer?\",\"answer\":\"Kidney cancer had an age-standardized rate (ASR) of 2.32 per 100,000, while bladder cancer had an ASR of 5.93 per 100,000.\"},{\"question\":\"Were incidence trends increasing over time, and who had higher rates?\",\"answer\":\"Estimated annual percentage change indicated an increase in incidence for both kidney and bladder cancers. Men and urban residents experienced higher incidence rates than women and rural residents.\"}]","Trends in urinary tract cancer incidence in Golestan province, Iran - a 16-year population-based study | PDF",1790164847,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1927bdc32b64d590f8ea9b9795c5dba2.webp",983,1310,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/402c884badacadec7913d7370ca2d7ec.webp",982,1309,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91ce8504886dd399316b46065b2f5011.webp",981,1308,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/152211dd34bb97e49a453fe58dec5c96.webp",980,1306]